centrifugation and separation. Plasma biochemical analysis (Idexx laboratories), 150 packed cell volume and total protein evaluation were routinely performed for all 151 cats on enrollment to the longitudinal monitoring programme. Total serum 152 thyroxine concentration was measured in all cats in which the history (e.g. 153 polyphagia, weight loss), physical examination findings (e.g. tachycardia, 154 arrhythmia, poor body condition, palpable goiter), or serum biochemical findings 155 (increased alanine transferase or alkaline phosphatase activities) raised concern 156 for hyperthyroidism. In all cases in which the urinary bladder was palpable, a 157 urine sample was collected by cystocentesis. For every cat enrolled in the 158 longitudinal monitoring programme residual sample (EDTA, serum, heparinised 159 plasma) and EDTA cell pellets mixed with a 1:1 ratio of EDTA-phosphate buffered 160 saline were stored at −80°C, the latter to be used for genomic DNA extraction. 161
162
Cats that were considered healthy on the basis of these data were offered re-163 examination on a 6-monthly basis. Cats were diagnosed with azotaemic CKD if 164 plasma creatinine was greater than laboratory reference interval (177 µmol/L) on 165 two occasions a minimum of 4 weeks apart in association with inappropriate urine 166 concentrating ability (urine specific gravity<1·035). Cats were diagnosed with 167 systemic HT if SBP was greater than 170 mmHg on one occasion in association 168 with hypertensive ocular target organ damage or if SBP greater than 170 mmHg 169 on at least two occasions. study. Ultimately, all cats identified from the computerised database fulfilling the 209 inclusion and exclusion requirements and from which genomic DNA was available 210 were used in this study. Sample size was therefore driven by availability. Genomics]. This produced two allele-specific oligonucleotides with unique 5′ 254 tails and one common reverse oligonucleotide. For each genotyping assay, the 255 allele-specific and common primers were diluted in nucleic acid-free H2O to a final 256 concentration of 100 μM and combined as a SNP-specific assay mix (12 μL allele-257 specific primer 1+12 μL allele-specific primer 2+30 μL common primer+46 μL 258 dH2O). Buffer mix was prepared using KASP™ assay mix (KBS Weinberg equilibrium (HWE; using the exact Hardy-Weinberg test) and linkage 295 disequilibrium (LD) were evaluated. MAF greater than 10% was chosen to include 296 only common variants and therefore to improve power to detect a significant 297 association given the relatively small sample size. For quality control, summarystatistics were checked for the genotype call rates per SNP and per cat, and a SNP 299 call rate threshold of greater than 90% was used. Pairwise LD values were 300 calculated in PLINK using data from our cohort of cats due to lack of available 301 known feline LD reference data (unlike in human GWAS). An r2 value of >0·5 was 302 used based on suggested threshold from PLINK of 0·5 "being necessary to declare 303 that one SNP tags another" (Purcell et al. 2007 ). An additive model was used for 304 all SNP associations, with results corresponding to a per allele unit effect. For 305 genotyping analyses Bonferroni correction was applied to adjust for multiple 306 testing. Based on pairwise LD the SNPs reduced to a set of five pairwise 307 independent SNPs (Table S2 ) and therefore for genotyping analyses statistical 308 significance was defined as P<0·01 (using Bonferroni correction: P=0·05/5). and was documented to be well-controlled, both on the basis of clinical signs and 336 total thyroxine measurement (n=44 median total thyroxine 22·9 nmol/L; IQR 17·1 337 to 31·7 nmol/L). Twenty-one of the cats that had been diagnosed with 338 hyperthyroidism had previously undergone either uni-or bi-lateral 339 thyroidectomy and therefore were not receiving any antithyroid medication at the 340 point of enrollment. At the time of initial assessment 33·9% (77/227) of cats had 341 been diagnosed with azotaemic CKD. Clinical data are compared between cats 342 diagnosed with azotaemic CKD and non-azotaemic cats at entry to the study in 343 Table 2 . As may be anticipated cats diagnosed with azotaemic CKD had 344 significantly higher plasma creatinine concentration, lower packed cell volume 345 and urine specific gravity. Potassium concentration was unexpectedly 346 significantly higher in cats with azotaemic CKD (P=0·034) and, despite selectionof cats from the 14th year of life, cats with azotaemic CKD at enrollment were 348 younger (P=0·02) than non-azotaemic cats. Table 4 . 378
379
A further three exonic UMOD SNPs were identified using recently published data 380 by Tamazian et al. (Table 4) . Two of these SNPs (g.1381T>A and g.1664A>G) are 381 non-synonymous and located in exon 2; one is a synonymous SNP (g.4635T>C) 382 located in exon 5 (Fig S1) . Polyphen was used to predict the impact of the amino 383 acid substitution on the structure and function for both non-synonymous SNPs 384 (Adzhubei et al. 2010 ). The two SNPs were considered as benign (g.1381T>A, 385 p.ser74thr: score 0·009, sensitivity 0·96, specificity 0·77 and g.1664A>G, 386 p.asp168gly: score 0·002, sensitivity 0·99, specificity 0·3). KASP™ assays were 387 designed for all three SNPs but were successful for only two (exonic g.1381T>A 388
and intronic g.4635T>C). Ultimately the exonic non-synonymous SNP g.1381T>A 389 which was considered benign using Polyphen modelling did not have a MAF 390 greater than 10% and therefore was not evaluated within association studies. 391
Genotyping frequency data are presented in However, given the relatively small sample size all cats were retained in the study. 400
Evaluating genotype data from all cats, seven SNPs had a MAF greater than 10% 401 (Table 4 ) and were used for further evaluation, restricting to analysis of common 402 variants as appropriate for this sample size. HWE data are presented in Table 4 . 403 LD pairwise comparison identified that there were five independent SNPs (Table  404 S2; g.4635T>C, g.1381T>A, g.6902C>T, g.3390G>A and 5′ upstream 1372 bp 405
G>A). 406 407 Association between UMOD genotype and renal function 408
Seven SNPs with MAF greater than 10% (Table 4) were analysed for associations 409 with renal function using the quantitative trait log-creatinine and the binary 410 outcome of being diagnosed with azotaemic CKD in 15th year of life or being non-411 azotaemic. We observed no significant association between SNPs and log-412 creatinine (Table S3) . Similarly there were no SNPs significantly associated with 413 the diagnosis of CKD as a binary variable (all had P>0·01; Table S4).  414   415 Association between UMOD genotype, systolic blood pressure and systemic 416 hypertension 417
After exclusion of cats that were receiving antihypertensive or BP-modifying 418 medication at the time of enrollment, 188 cats were available for evaluation of 419 association between genotype and SBP as a continuous variable (Table S6) . Seven 420
SNPs demonstrated MAF greater than 10% (Table S5 ) and were included in the 421 analysis (Table S6) . Four SNPs were significantly associated (P<0·01 ; Table 5) with SBP as a quantitative variable, adjusted for plasma creatinine as a covariate 423 (Table S6 ) but all four were in LD, suggesting one overall distinct association 424
signal. 425 426
Clinical record data for all 227 cats were reviewed in order to categorise cats as 427 normotensive or hypertensive during their period of follow-up at the clinics 428 (Table 3) . No SNPs with MAF greater than 10% were significantly associated with 429 the hypertensive state (all had P>0·01; Table S7 ). with SBP were not independent and shown to be in LD. There is relatively little 441 known about LD in cats and the values generated for the current study were 442 inferred from this population alone using an LD r2 value that was lower than 443 typically applied to human studies (Alhaddad et al. 2013 ). The SNPs where 444 significant association was identified were intronic. Therefore any effect from 445 these SNPs will not be the result of structural change in the uromodulin amino 446 acid sequence but could reflect, for example, alteration in splicing or posttranslational modifications (Shastry 2009 ). The overall effect of SNPs significantly 448 associated with SBP in this study appears proportionally large compared to effects 449 identified in human medicine. It can be hypothesised that potentially the cat may 450 be different from the human in terms of the complexity of SBP as a trait giving rise 451 to this greater effect. However, further work is required to validate the SNPs 452 identified in independent cohorts of cats in order to establish this association. wild-type mice (Graham et al. 2014) . Cells from the TAL were isolated from wild-488 type mice and stimulated with TNFα resulting in a reduction in NKCC2 expression, 489 and simultaneous increase in UMOD mRNA expression (Graham et al. 2014 ). This 490 work suggests that uromodulin modulates the effect of TNFα on NKCC2 491 expression and hence may affect BP regulation. However, further work is required 492 to exactly characterise this molecular mechanism. To date, although studies report 493 the measurement of uromodulin in cats using experimental collection of large 494 volumes of urine, it has not been possible to validate a human-based ELISA system 495 for urine uromodulin quantification (Lulich et al. 2012 ). Nevertheless, this wouldbe an interesting avenue for further study in order to explore the relationship 497 between genetic variation and uromodulin expression in cats. 498
499
In contrast to data from human medicine, no association could be identified 500 between genetic variants in UMOD and plasma creatinine as a marker of renal 501 function or the outcome of a diagnosis of CKD. In human medicine, a significant 502 association has been identified between UMOD variant rs12917707 and CKD 503 defined as an estimated GFR (eGFRcreat) using creatinine (eGFRcreat) of <60 504 mL/kg/minute/1·73 m2 in both discovery and replication groups (Kottgen et al. renal function is smaller than that for BP, lack of association with renal function 518 in the current study may reflect the small sample size. In the current study every 519 available cat meeting the study criteria was included. Given this available sample 520 size, we have performed power calculations retrospectively (Purcell et al. 2003 ) 521 to estimate the expected power achievable from an analysis of N=227 cats for 522 detecting effects of associated SNPs with MAF≥10%. For BP traits, which are 523 known to only have small effects for each SNP individually in humans, the sample 524 of 227 cats may only have ~20% power. For renal trait associations, for which we 525 anticipate higher power, as human studies indicate larger effect sizes, the sample 526 of 227 cats may have ~40% power. These calculations include estimates and 527 assumptions for heritability and LD structure known from human genetics. 528 However, with no prior GWAS of BP and renal traits in cats, the accuracy of these 529 estimates is unknown. Analysis of this pilot study data and the quality control 530 diagnostics performed suggest that there may be stronger LD structure within 531 cats, compared to humans. If this is the case, the power could actually be higher 532 than has been estimated, which may explain the successful identification of 533 associations among UMOD SNPs and SBP. Equally the small sample size means 534 that there is insufficient evidence to conclude absence of a significant association 535 between UMOD variants and HT or renal traits from this study. 536 537 Although a range of intronic and exonic SNPs were evaluated in this study only 5 538 out of 11 were ultimately identified to be independent, and therefore there were 539 only a limited number of distinct signals that could be analysed for these data. 540
Furthermore, in the current study, plasma creatinine was used as a marker of GFR 541 whilst in comparable human studies estimated GFR based on either creatinine or 542 cystatin C were commonly used. Creatinine is recognised to be a less precise 543 marker of GFR particularly in the early stages of CKD than estimated GFR 544 calculations. It is therefore possible that as yet undiscovered SNPs in the feline 545 hyperthyroidism results in a reduction in systemic vascular resistance that is 557 offset by an increase in cardiac output, thus the net effect of hyperthyroidism is 558 towards a small decline in blood pressure (Syme 2007) . The underlying 559 pathophysiology of systemic HT documented in cats with hyperthyroidism 560 remains to be determined, but may relate to the decline in renal function identified 561 with return to euthyroidism (Williams et al. 2010 (Williams et al. , 2013 . If this is the case then it 562 remains possible that genetic variants, such as those identified in uromodulin, 563
could be common to all cats and still play a predisposing role in the development 564 of systemic HT. Every attempt was made to ensure that cats were truly euthyroid 565 at the point of inclusion aged 14 years. It is therefore hoped that any effect of a 566 prior diagnosis of hyperthyroidism on both SBP and renal function as assessed by 567 plasma creatinine will have been minimised at this time. The association analysis 568 for SBP was repeated excluding cats that were receiving medical therapy for their 569 hyperthyroidism without documenting any change in association results (data not 570 presented) implying that inclusion of these cats did not adversely affect the 571 results. However, despite careful longitudinal monitoring, it is possible that either 572 failure to make an early diagnosis of hyperthyroidism or medical management of 573 hyperthyroidism in those patients where a diagnosis was made, could have 574 impacted on our ability to define cats as hypertensive during follow-up. was not performed in the current study on cats but which has been evaluated in 583 human medicine is the association between genetic variants and progression of 584 renal disease (Gorski et al. 2015 
